NEW YORK (GenomeWeb) – Liquid-based cytology diagnostics firm Novacyt today announced its intention to combine with Lab21 in a stock-for-stock transaction valued at approximately €40 million ($34.1 million).
Registering provides access to this and other free content.
Already have an account?Login Now.
The startup incubator Y Combinator is launching a nonprofit research lab.
In Nature this week: genomic analysis of 200 bird species, and more.
The Australian High Court rules that isolated genetic material cannot be patented.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.